Health Catalyst, Inc. — Director's Dealing 2021

Jun 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-06-15

Reporting Person: Pramoda Anita (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-15	Common Stock	S	4542.00	$56.4222	Disposed	4186.00	Direct
2021-06-15	Common Stock	S	901.00	$57.0802	Disposed	3285.00	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4348.00	Indirect

Footnotes

F1: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1.

F2: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $55.94 to $56.87, inclusive.

F3: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $57.01 to $57.15, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3).

F4: The shares are held by Omkara, LLC and the Reporting Person wholly-owns and holds the voting and dispositive power of these shares.